KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Diluted Average): 2017-2024

Historic Shares Outstanding (Diluted Average) for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $497.3 million.

  • Elanco Animal Health's Shares Outstanding (Diluted Average) rose 0.70% to $501.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.2 million, marking a year-over-year increase of 0.70%. This contributed to the annual value of $497.3 million for FY2024, which is 1.02% up from last year.
  • Elanco Animal Health's Shares Outstanding (Diluted Average) amounted to $497.3 million in FY2024, which was up 1.02% from $492.3 million recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Shares Outstanding (Diluted Average) ranged from a high of $497.3 million in FY2024 and a low of $441.4 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $492.3 million (2023), whereas its average is $492.6 million.
  • Data for Elanco Animal Health's Shares Outstanding (Diluted Average) shows a peak YoY increased of 19.20% (in 2020) over the last 5 years.
  • Elanco Animal Health's Shares Outstanding (Diluted Average) (Yearly) stood at $441.4 million in 2020, then climbed by 10.38% to $487.2 million in 2021, then rose by 0.23% to $488.3 million in 2022, then climbed by 0.82% to $492.3 million in 2023, then grew by 1.02% to $497.3 million in 2024.